Personalized Risk Information in Cost Effectiveness Studies (PRICES)
Responding to a call from the NIH to develop an economic framework for personalized medicine, the Tufts Predictive Analytics and Comparative Effectiveness (PACE) Center and the Center for the Evaluation of Value and Risk, both at Tufts Medical Center, collaborated on a proposal to explore the value of providing clinicians and patients with information regarding each patient's individualized risk of having bad health outcomes so that clinicians can better tailor care.
A disease simulation model will be developed to determine the optimal strategy in terms of cost-effectiveness for different risk groups of individuals based on participants prescreening risk of lung-cancer death.The NLST data will be utilized to populate the model.
Medical Decision Making research group at the Department of Public Health at Erasmus Medical Center in Rotterdam, The Netherlands.
Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
Kumar V, Cohen JT, van Klaveren D, Soeteman DI, Wong JB, Neumann PJ, Kent DM
Ann. Intern. Med. 2018; Volume 168 (Issue 3): Pages 161-169 PUBMED